Friday, November 17, 2023 11:31:16 AM
Instead he scooped the shareholders on the distressed asset and took the sweet deal for himself. Now here we are presented with an invoice for the millions of dollars we owe him, and the president of the Nasrat Booster Club takes it as direct proof of how awesome he is and everyone should just shut up and worship. Good lord.
You are simply wrong. Its like saying SpaceX couldn't buy a building Tesla operates out of and charge Tesla to rent it. As long as the board of directors of Tesla OKs it its above the board. The most you can whine and moan about is Elite's board agreeing with Carter that Elite should not buy the other half of Adderall. The board has to approve everything. For instance they had to approve the facility expansion. Nasrat went out of his way to point out he got the boards approval.
Elite did NOT have the money to buy the other half of the Adderall. I know you don't agree or feel they should of pawned whatever they could to get the money. But the board and plenty of investors disagree with you. If Elite had done what you suggested get the money to buy the other half of the Adderall by whatever means necessary we would not have the following because they wouldn't have had the money to purchase all of these
- THREE needle mover products released by end of year next year
- Upgraded equipment to meet the manufacturing demands of the sales Kirkov is making
- The money to purchase additional property (either with cash or best interest rates possible) to expand facilities by June 2024.
In addition they wouldn't have had good capital and little debt to purchase their building, right now instead they may have been stuck renting a building with increasing rent and costs.
You have been bitching and moaning for years and selling shares. Keep doing that cause your good at it but I am very glad I believed and invested heavily since August (when it became crystal clear how much growth we were going to experience in the next few years). I am up over $90k just on the shares that I invested since August...so I am feeling very good about my perspective on the company.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
